Share This Page
Suppliers and packagers for PREDNISONE INTENSOL
✉ Email this page to a colleague
PREDNISONE INTENSOL
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Hikma | PREDNISONE INTENSOL | prednisone | SOLUTION;ORAL | 088810 | ANDA | Hikma Pharmaceuticals USA Inc. | 0054-3721-44 | 30 mL in 1 BOTTLE, GLASS (0054-3721-44) | 1985-02-20 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: PREDNISONE INTENSOL
Introduction
Prednisone Intensol is a specific formulation of prednisone, a synthetic corticosteroid widely used in the management of inflammatory and autoimmune conditions. As a potent glucocorticoid, prednisone reduces immune responses and inflammation, making it vital in clinical settings. The supply chain for Prednisone Intensol involves multiple manufacturers spanning pharmaceuticals, generic drug producers, and specialty chemical firms. An understanding of these suppliers is critical for stakeholders involved in procurement, distribution, and manufacturing of this essential medication.
Market Overview and Regulatory Landscape
Prednisone specifications are governed by stringent regulatory frameworks, notably by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The active pharmaceutical ingredient (API), prednisone, must meet rigorous purity and bioavailability standards. Suppliers typically include both brand-name manufacturers and generic producers who manufacture the API and finished dosage forms (FDFs).
The market for prednisone APIs and formulations has experienced consolidation, driven by patent expirations and increased demand for corticosteroid therapies worldwide. Companies engaging in the supply of Prednisone Intensol must also navigate compliance standards, Good Manufacturing Practices (GMP), and international quality certifications.
Key Suppliers of Prednisone API
Major Global API Manufacturers
1. Pfizer Inc.
Pfizer is one of the original patent holders of prednisone and still supplies high-grade APIs and formulations. Its global manufacturing facilities adhere to stringent quality standards, and Pfizer's API products are widely used in generic formulations.
2. Sun Pharmaceutical Industries Ltd.
Sun Pharma produces prednisone API with a focus on cost-effective manufacturing. The company operates multiple GMP-certified plants and supplies to various pharmaceutical companies worldwide.
3. Mylan N.V. (now part of Viatris)
Mylan is a significant player in generic APIs, including prednisone. Their production facilities comply with international standards, and they supply both APIs and finished dosage forms to global markets.
4. Sandoz (Novartis)
Sandoz, a division of Novartis, is renowned for its high-quality generic APIs, including corticosteroids such as prednisone, with a robust distribution network globally.
5. Teva Pharmaceutical Industries Ltd.
Teva, notable for its large-scale production of generic medicines, manufactures prednisone API and related corticosteroids, catering primarily to North American and European markets.
Specialized API Suppliers
Some smaller or regional companies specialize in steroid APIs or operate as excipient suppliers, sourcing prednisone APIs for broader formulation purposes.
Finished Dosage Form Suppliers and Formulation Manufacturers
1. Pharmaceutical Contract Manufacturing Organizations (CMOs)
Major CMOs such as Hospira (Pfizer subsidiary), Patheon (Thermo Fisher Scientific), and Catalent provide the manufacturing of Prednisone Intensol's liquid formulation, often sourcing API from recognized API suppliers.
2. Regional Generic Pharmaceutical Companies
Numerous regional players in India, China, and Eastern Europe manufacture Prednisone Intensol under local regulatory approvals. For example, Zydus Cadila and Dr. Reddy’s Laboratories are involved in producing corticosteroid formulations, including prednisone solutions.
3. Brand Manufacturers
While Prednisone Intensol is often available as a generic, some companies produce branded formulations for markets requiring specific labeling or formulation nuances.
Distribution and Supply Chain Dynamics
The supply chain for Prednisone Intensol comprises multiple stages: raw material sourcing, API manufacturing, formulation, packaging, and distribution. Given the global demand, supply chain disruptions—such as raw material shortages, regulatory delays, or geopolitical issues—have historically impacted drug availability.
Strategic partnerships, stockpiling, and diversified sourcing by pharmaceutical companies help mitigate risks. Patent expirations of key formulations have increased competition among generic suppliers, further affecting pricing and availability.
Emerging Trends Influencing Suppliers
- Vertical Integration: Some firms are vertically integrating to control both API manufacturing and formulation, reducing dependency on external suppliers and ensuring supply consistency.
- Quality Certification & Regulatory Approvals: Suppliers emphasizing compliance with CMC (Chemistry, Manufacturing, and Controls) standards are favored, especially in regulated markets like the U.S. and EU.
- Sustainability & Cost Efficiency: Increasing focus on environmentally sustainable manufacturing processes and cost-effective production to meet global demand while maintaining quality.
- Supply Chain Resilience: The COVID-19 pandemic underscored the importance of diversified, resilient supply networks for corticosteroids, prompting companies to broaden supplier bases.
Key Takeaways
- Major API suppliers for prednisone include Pfizer, Sun Pharma, Mylan, Sandoz, and Teva, with regional manufacturers supplementing global supply.
- Finished formulation manufacturing is primarily conducted by CMOs and regional pharmaceutical companies, emphasizing quality compliance.
- Supply chain stability depends on diversified sourcing, regulatory adherence, and proactive risk management, especially as market demand fluctuates.
- Emerging trends like vertical integration and sustainability initiatives influence supplier selection and competitiveness.
- Regulatory alignment remains critical; suppliers must hold requisite certifications such as FDA approval, EMA certification, or WHO prequalification to enter regulated markets.
FAQs
Q1: Who are the leading global manufacturers of prednisone API?
A1: Pfizer, Sun Pharma, Mylan (Viatris), Sandoz, and Teva are recognized as the leading API manufacturers of prednisone, offering high-quality, GMP-compliant products.
Q2: Are there regional differences in Prednisone Intensol suppliers?
A2: Yes, regional markets often rely on local manufacturers—e.g., Indian and Chinese companies for cost-effective API sourcing—complemented by global firms for quality assurance.
Q3: How does regulatory compliance impact supplier selection?
A3: Suppliers must meet regulatory standards such as FDA, EMA, or WHO prequalification to ensure product quality and market access, influencing procurement decisions significantly.
Q4: What role do Contract Manufacturing Organizations play in the supply of Prednisone Intensol?
A4: CMOs produce finished dosage forms, including Prednisone Intensol, often sourcing API from trusted API manufacturers. They enable scalability and compliance with manufacturing standards.
Q5: How might supply chain disruptions affect Prednisone Intensol availability?
A5: Disruptions in raw material supply, geopolitical issues, or regulatory delays can lead to shortages, emphasizing the need for diversified sourcing and strategic stockpiling.
Conclusion
The supply landscape for Prednisone Intensol is characterized by a combination of established API manufacturers and specialized formulation producers operating under strict regulatory standards. With increasing global demand and evolving market dynamics, stakeholders must prioritize supplier quality, regulatory compliance, and supply chain resilience. Strategic partnerships and diversification remain essential to ensure consistent availability of this vital corticosteroid for therapeutic needs worldwide.
References
- U.S. Food and Drug Administration (FDA). https://www.fda.gov
- European Medicines Agency (EMA). https://www.ema.europa.eu
- IQVIA Institute. (2022). Global pharmaceutical market analysis.
- Global Pharmacovigilance and API manufacturer directories.
- Company websites and annual reports of Pfizer, Sun Pharma, Mylan, Sandoz, and Teva.
More… ↓
